Bioavailability & Bioequivalence Studies:
Companies conduct bioavailability
studies both at the beginning of human testing and just prior
to marketing to show that the formulation used to demonstrate
safety and efficacy in clinical trials is equivalent to the
product that will be distributed for sale.
Companies also conduct bioavailability
studies on marketed products whenever they change the method
used to administer the drug (e.g., from injection or oral
dose form), the composition of the drug, the concentration
of the active ingredient, or the manufacturing process used
to produce the drug.
A team of senior pharmacist &
chemists is behind the Repharm Services for conducting Bioavailability
& Bioequvelence Studies. The team members have also completed
Bioavaliability studies and 1 Bioequvelence Studies for national
companies. Some of these are as follows;
Please lets know if you are interested
to get these studies conducted for your molecules. more.........
- Diltiazime HCl
- Mefenamic Acid
- Metformin HCl
- Ranitidine HCl and many more